— Why it moved
Why GCTK Stock Spiked and Faded Today — September 24, 2026
GlucoTrack gapped up premarket on commercial news before a discounted offering crushed the move, leaving an eleven percent exit window.
What moved GCTK stock
GlucoTrack is a micro-cap biotech focused on diabetes monitoring and therapeutic platforms. The company announced its first commercial client for its Lōkahi platform alongside a $3.1 million direct public offering. Chasers bought the initial headline pop, ignoring that the new shares were being sold to institutions at $2.04.
The mechanics
A tiny float of 636,246 shares made a 91.63% gap trivial to ignite during early premarket trading. Once dilution reality set in, 51.3 million shares traded hands, churning the float over 80 times.
GCTK by the numbers
The alert window
The alert hit at 6:47 AM at 4.30. You sat through a 4.7% dip down to 4.10 before it pushed to 4.78 at 7:00 AM. That gave you 13 minutes for an 11.2% scalp. After 25 minutes above alert, it broke down and never looked back.
How GCTK's move ended
It closed at 2.58, down 40.0% from the alert price. Dilution priced down at 2.04 capped the move, leaving morning chasers holding heavy bags.
The tell: When a micro-cap gaps on news paired with a discounted public offering, early premarket strength is usually exit liquidity.